Raymond James Reiterates Strong Buy on Greenway Medical Technologies Following Acquisition Announcement

In a report published Tuesday, Raymond James analyst Alexander Y. Draper reiterated a Strong Buy rating on Greenway Medical Technologies (NYSE: GWAY ). In the report, Raymond James noted, “After the close on Monday, Greenway entered into a definitive agreement to be purchased for $20.35 per share by Vista Equity